Company · CIK 0001228627 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
Opus Genetics, Inc. · IRD
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 9, 2026 FMForm 4 → | Sep 11, 4:09 pm EDT | George MagrathChief Executive Officer, Director | 467,698 | $1.93 | $901,960 | 2,048,485 | — | |
| Sep 8, 2026 MForm 4 → | Sep 8, 4:05 pm EDT | Cam GallagherDirector | 784,314 | $1.15 | $901,961 | 2,800,111 | — | |
| Sep 3, 2026 SForm 4 → | Sep 8, 4:05 pm EDT | Robert E. GagnonChief Financial Officer | 28,000 | $4.54 | $127,212 | 556,375 | −4.79% | |
| Jul 23, 2026 SForm 4 → | Jul 27, 4:08 pm EDT | Benjamin R YerxaPresident, Director | 7,429 | $2.97 | $22,064 | 704,106 | −1.04% | |
| Jul 23, 2026 SForm 4 → | Jul 27, 4:07 pm EDT | Joseph K SchachleChief Operating Officer | 4,644 | $2.94 | $13,653 | 291,440 | −1.57% | |
| Jul 23, 2026 SForm 4 → | Jul 27, 4:07 pm EDT | George MagrathChief Executive Officer, Director | 9,475 | $2.95 | $27,926 | 1,731,869 | −0.54% | |
| Jul 23, 2026 SForm 4 → | Jul 27, 4:06 pm EDT | Robert E. GagnonChief Financial Officer | 7,783 | $2.95 | $22,942 | 584,375 | −1.31% | |
| Feb 28, 2019 MForm 4 → | Mar 1, 5:41 pm EST | Lisa NolanChief Business Officer | 1,625 | — | — | 23,250 | — | plan? |
| Feb 28, 2019 MForm 4 → | Mar 1, 5:35 pm EST | Ely BenaimChief Medical Officer | 2,375 | — | — | 4,750 | — | plan? |
| Jan 31, 2019 PForm 4 → | Feb 4, 4:53 pm EST | Charles BeeverDirector | 10,000 | $0.638 | $6,380 | 11,000 | +1,000% | plan? |
| Jan 30, 2019 PForm 4 → | Jan 31, 7:48 am EST | Lisa NolanChief Business Officer | 20,000 | $0.648 | $12,960 | 21,625 | +1,231% | plan? |
| Jan 29, 2019 PForm 4 → | Jan 31, 7:56 am EST | Ben Gil PriceDirector | 15,000 | $0.6094 | $9,141 | 15,000 | — | plan? |
| Jan 29, 2019 PForm 4 → | Jan 30, 7:32 am EST | Douglas J SwirskyPresident and CEO, Director | 50,000 | $0.6344 | $31,720 | 50,000 | — | plan? |
| Feb 28, 2018 MForm 4 → | Mar 2, 4:44 pm EST | Lisa NolanChief Business Officer | 1,625 | — | — | 1,625 | — | plan? |
| Feb 28, 2018 MForm 4 → | Mar 2, 4:39 pm EST | Ely BenaimChief Medical Officer | 2,375 | — | — | 2,375 | — | plan? |
| Feb 28, 2018 MForm 4 → | Mar 2, 4:26 pm EST | Peter David SuzdakChief Executive Officer, Director | 6,250 | — | — | 22,250 | — | plan? |
| Aug 16, 2017 AForm 4 → | Aug 16, 4:05 pm EDT | Peter David SuzdakChief Executive Officer, Director | 10,000 | $1.99 | $19,872 | 16,000 | — | plan? |
| Apr 10, 2017 SForm 4 → | Apr 12, 5:26 pm EDT | Chang Ho AhnDirector | 250,000 | $0.7015 | $175,375 | 6,010,000 | −3.99% | plan? |
| Apr 10, 2017 MForm 4 → | Apr 12, 5:26 pm EDT | Chang Ho AhnDirector | 250,000 | $0.31 | $77,500 | 6,260,000 | — | plan? |
| Mar 18, 2016 AForm 4 → | Mar 21, 9:20 pm EDT | Peter David SuzdakChief Executive Officer, Director | 60,000 | $0.3231 | $19,386 | 60,000 | — | plan? |
| Jan 8, 2015 SForm 4 → | Jan 12, 6:22 pm EST | Tae Heum JeongChief Financial Officer | 317,272 | $0.9113 | $289,136 | 505,000 | −38.6% | plan? |
| Jan 8, 2015 MForm 4 → | Jan 12, 6:22 pm EST | Tae Heum JeongChief Financial Officer | 317,272 | $0.80 | $253,818 | 554,800 | — | plan? |
| Jan 8, 2015 SForm 4 → | Jan 12, 6:11 pm EST | Chang Ho AhnDirector | 314,656 | $0.9114 | $286,772 | 6,010,000 | −4.98% | plan? |
| Jan 8, 2015 MForm 4 → | Jan 12, 6:11 pm EST | Chang Ho AhnDirector | 314,656 | $0.80 | $251,725 | 6,058,444 | — | plan? |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 9, 2026 MForm 4 → | Sep 11, 4:09 pm EDT | George MagrathChief Executive Officer, Director | 392,157 | — | — | 0 | — | |
| Sep 8, 2026 MForm 4 → | Sep 8, 4:05 pm EDT | Cam GallagherDirector | 784,314 | — | — | 0 | — | |
| Feb 28, 2019 MForm 4 → | Mar 1, 5:41 pm EST | Lisa NolanChief Business Officer | 1,625 | — | — | 3,250 | — | |
| Feb 28, 2019 MForm 4 → | Mar 1, 5:35 pm EST | Ely BenaimChief Medical Officer | 2,375 | — | — | 4,750 | — | |
| Feb 27, 2019 AForm 4 → | Mar 1, 5:31 pm EST | Lara SullivanDirector | 84,968 | — | — | 84,968 | — | |
| Jan 25, 2019 AForm 4 → | Jan 25, 7:54 pm EST | Lisa NolanChief Business Officer | 130,000 | — | — | 130,000 | — | |
| Jan 25, 2019 AForm 4 → | Jan 25, 7:52 pm EST | Ely BenaimChief Medical Officer | 100,000 | — | — | 100,000 | — | |
| Nov 29, 2018 AForm 4 → | Dec 3, 5:10 pm EST | Ben Gil PriceDirector | 112,878 | — | — | 112,878 | — | |
| Nov 14, 2018 AForm 4 → | Nov 16, 4:54 pm EST | Douglas J SwirskyPresident and CEO, Director | 500,000 | — | — | 500,000 | — | |
| Jun 28, 2018 AForm 4 → | Jun 29, 4:45 pm EDT | Charles BeeverDirector | 39,742 | — | — | 39,742 | — | |
| Jun 28, 2018 AForm 4 → | Jun 29, 4:40 pm EDT | Peter C. BrandtDirector | 39,742 | — | — | 39,742 | — | |
| Jun 28, 2018 AForm 4 → | Jun 29, 4:34 pm EDT | Richard J RodgersDirector | 39,742 | — | — | 39,742 | — | |
| Jun 28, 2018 AForm 4 → | Jun 29, 4:33 pm EDT | Kwang Soo CheongDirector | 39,742 | — | — | 39,742 | — | |
| Mar 7, 2018 AForm 4 → | Mar 9, 5:12 pm EST | Ely BenaimChief Medical Officer | 200,000 | — | — | 200,000 | — | |
| Feb 28, 2018 MForm 4 → | Mar 2, 4:44 pm EST | Lisa NolanChief Business Officer | 1,625 | — | — | 4,875 | — | |
| Feb 28, 2018 MForm 4 → | Mar 2, 4:39 pm EST | Ely BenaimChief Medical Officer | 2,375 | — | — | 7,125 | — | |
| Feb 28, 2018 MForm 4 → | Mar 2, 4:26 pm EST | Peter David SuzdakChief Executive Officer, Director | 6,250 | — | — | 18,750 | — | |
| Jan 26, 2018 AForm 4 → | Jan 30, 4:39 pm EST | Peter David SuzdakChief Executive Officer, Director | 112,271 | — | — | 112,271 | — | |
| Jan 26, 2018 AForm 4 → | Jan 30, 4:31 pm EST | Lisa NolanChief Business Officer | 42,101 | — | — | 42,101 | — | |
| Jan 26, 2018 AForm 4 → | Jan 30, 4:26 pm EST | Ely BenaimChief Medical Officer | 45,443 | — | — | 45,443 | — | |
| Jan 2, 2018 AForm 4 → | Jan 4, 4:56 pm EST | Douglas J SwirskyPresident and CFO | 250,000 | — | — | 250,000 | — | |
| Apr 11, 2017 AForm 4 → | Apr 12, 5:28 pm EDT | Mark CarthyDirector | 110,000 | — | — | 110,000 | — | |
| Apr 11, 2017 AForm 4 → | Apr 12, 5:26 pm EDT | Kwang Soo CheongDirector | 110,000 | — | — | 110,000 | — | |
| Apr 11, 2017 AForm 4 → | Apr 12, 5:25 pm EDT | Richard J RodgersDirector | 110,000 | — | — | 110,000 | — | |
| Apr 11, 2017 AForm 4 → | Apr 12, 5:21 pm EDT | Peter C. BrandtDirector | 110,000 | — | — | 110,000 | — | |
| Apr 11, 2017 AForm 4 → | Apr 12, 5:20 pm EDT | Charles BeeverDirector | 110,000 | — | — | 110,000 | — | |
| Apr 10, 2017 MForm 4 → | Apr 12, 5:26 pm EDT | Chang Ho AhnDirector | 250,000 | — | — | 0 | — | |
| Jan 20, 2017 AForm 4 → | Jan 24, 5:52 pm EST | Tae Heum JeongChief Financial Officer | 363,000 | — | — | 63,000 | — | |
| Jan 20, 2017 AForm 4 → | Jan 24, 5:50 pm EST | Peter David SuzdakChief Executive Officer, Director | 1,425,000 | — | — | 250,000 | — | |
| Jan 20, 2017 AForm 4 → | Jan 24, 5:48 pm EST | Ely BenaimChief Medical Officer | 545,000 | — | — | 95,000 | — | |
| Jan 20, 2017 AForm 4 → | Jan 24, 5:45 pm EST | Lisa NolanChief Business Officer | 380,000 | — | — | 65,000 | — | |
| Jan 20, 2017 AForm 4 → | Jan 24, 5:42 pm EST | Chang Ho AhnDirector | 400,000 | — | — | 70,000 | — | |
| Jul 6, 2016 AForm 4 → | Jul 8, 4:44 pm EDT | Lisa NolanChief Business Officer | 1,200,000 | — | — | 1,200,000 | — | |
| Jun 9, 2016 AForm 4 → | Jun 10, 5:04 pm EDT | Richard J RodgersDirector | 225,000 | — | — | 225,000 | — | |
| Jun 9, 2016 AForm 4 → | Jun 10, 5:04 pm EDT | Mark CarthyDirector | 225,000 | — | — | 225,000 | — | |
| Jun 9, 2016 AForm 4 → | Jun 10, 5:00 pm EDT | Peter C. BrandtDirector | 225,000 | — | — | 225,000 | — | |
| Jun 9, 2016 AForm 4 → | Jun 10, 5:00 pm EDT | Charles BeeverDirector | 225,000 | — | — | 225,000 | — | |
| Jun 9, 2016 AForm 4 → | Jun 10, 5:00 pm EDT | Kwang Soo CheongDirector | 225,000 | — | — | 225,000 | — | |
| Jan 28, 2016 AForm 4 → | Feb 1, 4:35 pm EST | Ely BenaimChief Medical Officer | 598,734 | — | — | 500,000 | — | |
| Jan 28, 2016 AForm 4 → | Feb 1, 4:33 pm EST | Tae Heum JeongChief Financial Officer | 198,853 | — | — | 100,000 | — | |
| Jan 28, 2016 AForm 4 → | Feb 1, 4:32 pm EST | Peter David SuzdakChief Executive Officer, Director | 1,411,689 | — | — | 1,000,000 | — | |
| Jan 28, 2016 AForm 4 → | Feb 1, 4:32 pm EST | Chang Ho AhnDirector | 414,461 | — | — | 200,000 | — | |
| Sep 16, 2015 AForm 4 → | Sep 18, 4:47 pm EDT | Richard J RodgersDirector | 90,000 | — | — | 90,000 | — | |
| Sep 16, 2015 AForm 4 → | Sep 18, 4:41 pm EDT | Kwang Soo CheongDirector | 90,000 | — | — | 90,000 | — | |
| Sep 16, 2015 AForm 4 → | Sep 18, 4:37 pm EDT | Mark CarthyDirector | 90,000 | — | — | 90,000 | — | |
| Sep 16, 2015 AForm 4 → | Sep 18, 4:33 pm EDT | Peter C. BrandtDirector | 90,000 | — | — | 90,000 | — | |
| Sep 16, 2015 AForm 4 → | Sep 18, 4:28 pm EDT | Charles BeeverDirector | 90,000 | — | — | 90,000 | — | |
| Feb 2, 2015 AForm 4 → | Feb 4, 4:48 pm EST | Ely BenaimChief Medical Officer | 1,200,000 | — | — | 1,200,000 | — | |
| Jan 23, 2015 AForm 4 → | Jan 27, 6:45 pm EST | Peter David SuzdakChief Executive Officer, Director | 1,100,000 | — | — | 1,100,000 | — | |
| Jan 23, 2015 AForm 4 → | Jan 27, 6:41 pm EST | Tae Heum JeongChief Financial Officer | 333,332 | — | — | 333,332 | — | |
| Jan 23, 2015 AForm 4 → | Jan 27, 6:38 pm EST | Chang Ho AhnDirector | 333,332 | — | — | 333,332 | — | |
| Jan 8, 2015 MForm 4 → | Jan 12, 6:22 pm EST | Tae Heum JeongChief Financial Officer | 317,272 | — | — | 182,728 | — | |
| Jan 8, 2015 MForm 4 → | Jan 12, 6:11 pm EST | Chang Ho AhnDirector | 314,656 | — | — | 549,151 | — |